- Report
- November 2021
- 220 Pages
Global
From €2316EUR$2,400USD£1,987GBP
- Report
- October 2022
- 270 Pages
Global
From €3619EUR$3,750USD£3,105GBP
- Report
- August 2022
- 111 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- August 2022
- 118 Pages
Global
From €4585EUR$4,750USD£3,933GBP
- Report
- April 2023
- 180 Pages
Global
From €2896EUR$3,000USD£2,484GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2654EUR$2,750USD£2,277GBP
- Report
- December 2022
- 118 Pages
Global
From €4343EUR$4,500USD£3,726GBP
- Report
- August 2019
- 30 Pages
China
From €2123EUR$2,200USD£1,821GBP
- Report
- October 2023
- 75 Pages
India
From €3233EUR$3,350USD£2,774GBP
- Report
- March 2023
- 75 Pages
Spain
From €3233EUR$3,350USD£2,774GBP
- Report
- February 2023
- 135 Pages
Africa
From €3619EUR$3,750USD£3,105GBP
- Report
- January 2023
- 78 Pages
Africa
From €3233EUR$3,350USD£2,774GBP
- Report
- January 2023
- 78 Pages
Thailand
From €3233EUR$3,350USD£2,774GBP
- Report
- January 2023
- 70 Pages
Bangladesh
From €3233EUR$3,350USD£2,774GBP
- Report
- October 2022
- 72 Pages
Iran
From €3233EUR$3,350USD£2,774GBP
- Report
- October 2022
- 74 Pages
Indonesia
From €3233EUR$3,350USD£2,774GBP
- Report
- October 2022
- 72 Pages
China
From €3233EUR$3,350USD£2,774GBP
- Report
- October 2022
- 82 Pages
Asia Pacific
From €3619EUR$3,750USD£3,105GBP
- Report
- October 2022
- 73 Pages
Argentina
From €3233EUR$3,350USD£2,774GBP
- Report
- October 2022
- 80 Pages
Europe
From €3619EUR$3,750USD£3,105GBP
The Anti Rheumatic market is a subset of the Immune Disorders Drugs market, which focuses on the treatment of rheumatic diseases. These diseases are caused by an abnormal immune response, which can lead to inflammation and joint pain. Anti Rheumatic drugs are used to reduce inflammation and pain, as well as to prevent further damage to the joints. These drugs can be administered orally, intravenously, or topically. Commonly used Anti Rheumatic drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and biologic response modifiers.
Some companies in the Anti Rheumatic market include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, and Roche. Show Less Read more